Nautilus Biotechnology, Inc. (NAUT): Price and Financial Metrics


Nautilus Biotechnology, Inc. (NAUT): $1.96

0.03 (+1.55%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NAUT to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

NAUT Stock Price Chart Interactive Chart >

Price chart for NAUT

NAUT Price/Volume Stats

Current price $1.96 52-week high $5.07
Prev. close $1.93 52-week low $1.50
Day low $1.93 Volume 77,377
Day high $2.01 Avg. volume 146,259
50-day MA $1.79 Dividend yield N/A
200-day MA $2.56 Market Cap 244.46M

Nautilus Biotechnology, Inc. (NAUT) Company Bio


Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating platform technology for quantifying and unlocking the complexity of the proteome. It operates Nautilus Proteomic Analysis Platform, an integrated single-molecule protein analysis platform that leverages a nanofabricated, large-scale, single-molecule protein array, multi-cycle imaging, and machine learning analysis to potentially identify and quantify the proteome. The company was founded in 2016 and is headquartered in Seattle, Washington.


NAUT Latest News Stream


Event/Time News Detail
Loading, please wait...

NAUT Latest Social Stream


Loading social stream, please wait...

View Full NAUT Social Stream

Latest NAUT News From Around the Web

Below are the latest news stories about NAUTILUS BIOTECHNOLOGY INC that investors may wish to consider to help them evaluate NAUT as an investment opportunity.

Nautilus Biotechnology Launches “First Access Challenge”

Open competition allows researchers to be among the first to access potentially groundbreaking proteomic data through the testing of twelve samples on Nautilus’ single-molecule protein analysis platform Open competition allows researchers to be among the first to access potentially groundbreaking proteomic data through the testing of twelve samples on Nautilus’ single-molecule protein analysis platform

GlobeNewswire | November 16, 2022

Nautilus Biotechnology Reports Third Quarter 2022 Financial Results

SEATTLE, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial results for the third quarter ended September 30, 2022.

GlobeNewswire | November 1, 2022

Nautilus Biotechnology, Inc. (NAUT) Q3 2022 Earnings Call Transcript

Nautilus Biotechnology, Inc. (NASDAQ:NASDAQ:NAUT) Q3 2022 Earnings Conference Call November 01, 2022, 08:30 AM ET Company Participants Sujal Patel - Co-Founder and CEO Parag Mallick -…

Seeking Alpha | November 1, 2022

Nautilus Biotechnology GAAP EPS of -$0.11 beats by $0.03

Nautilus Biotechnology press release (NAUT): Q3 GAAP EPS of -$0.11 beats by $0.03.Cash, cash equivalents, and investments were $323.6M as of September 30, 2022.

Seeking Alpha | November 1, 2022

Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022

SEATTLE, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the third quarter 2022 before market open on Tuesday, November 1, 2022. The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments,

Yahoo | October 5, 2022

Read More 'NAUT' Stories Here

NAUT Price Returns

1-mo 8.89%
3-mo -10.50%
6-mo -30.50%
1-year -50.00%
3-year N/A
5-year N/A
YTD 8.89%
2022 -65.25%
2021 -52.26%
2020 N/A
2019 0.00%
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6335 seconds.